SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

PTCT.O (PTCT.O) News

Track canonical SquawkNews coverage tagged to PTCT.O, PTCT.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol PTCT.O Asset market Sector Markets 90 days 1 Updated Sep 21, 2026, 08:38 PM UTC Open live news feed
M PTC Therapeutics completes acquisition of Sangamo’s ST-920 Fabry gene therapy asset PTC Therapeutics completed its acquisition of Sangamo’s ST-920, a BLA-stage one-time AAV gene therapy for Fabry disease. A rolling BLA filing to the FDA for accelerated approval is expected to be completed in Q4 2026. ST EQUITY | Sep 21, 2026, 08:38 PM UTC